Form 8-K - Current report:
SEC Accession No. 0001493152-26-033358
Filing Date
2026-07-15
Accepted
2026-07-15 16:10:42
Documents
16
Period of Report
2026-07-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35843
2 EX-99.1 ex99-1.htm EX-99.1 25233
3 GRAPHIC ex99-1_001.jpg GRAPHIC 88198
4 GRAPHIC ex99-1_002.jpg GRAPHIC 46408
5 GRAPHIC ex99-1_003.jpg GRAPHIC 11451
6 GRAPHIC ex99-1_004.jpg GRAPHIC 12180
  Complete submission text file 0001493152-26-033358.txt   450801

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aztr-20260715.xsd EX-101.SCH 3017
8 XBRL LABEL FILE aztr-20260715_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE aztr-20260715_pre.xml EX-101.PRE 22360
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3196
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 261177499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)